A Study on the Safety & Tolerability of RGL-193 in Patients With Advanced

Updated 06/21/2024

Status Recruiting

Clinical Trial Summary

A safety study in patients with Parkinson's disease.

Clinical Trial Description

This is an open-label, dose-escalation safety and tolerability study in patients with advanced Parkinson's disease ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06195124
Study type	Interventional
Source	Second Affiliated Hospital of Soochow University
Contact	Chun-Feng Liu, MD
Phone	+8613606210609
Email	liuchunfeng@suda.edu.cn
Status	Recruiting
Phase	Early Phase 1
Start date	December 2023
Completion date	December 2024

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT02154724` - Clinical Study for Adaptive Deep Brain Stimulation (aDBS)Controlled by Intracerebral Activity in Parkinson's Disease	N/A
	Completed	`NCT02549092` - A Study to Examine the Effect of Levodopa-Carbidopa Intestinal Gel (LCIG) Therapy Relative to That of Optimized Medical Treatment (OMT) on Non-motor Symptoms (NMS) Associated With Advanced Parkinson's Disease (PD)	Phase 3
	Completed	`NCT01960842` - A Study to Assess the Efficacy, Safety and Tolerability of ABT-SLV187 Monotherapy in Subjects With Advanced Parkinson's Disease (PD) and Persistent Motor Complications, Despite Optimized Treatment With Available Anti-Parkinsonian Medications	Phase 3
	Completed	`NCT01723904` - A Phase 3b, Open-Label, Safety and Efficacy Study of Rotigotine as Add-On Therapy With Low Doses of Pramipexole or Ropinirole in Patients With Advanced Parkinson's Disease	Phase 3
	Completed	`NCT01479127` - Study of Safety, Tolerability, Pharmacokinetics, and Efficacy of ABT-SLV187 in Subjects With Advanced Parkinson's Disease	Phase 2
	Completed	`NCT03007888` - A Study to Assess the PK and Pharmacodynamics of IPX203 in Subjects With Advanced Parkinson's Disease	Phase 2
	Completed	`NCT00660673` - Open Label Continuation Treatment Study With Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease	Phase 3
	Active, not recruiting	`NCT04802733` - Phase 1 Safety and Tolerability Study of MSK-DA01 Cell Therapy for Advanced Parkinson's Disease	Phase 1
	Completed	`NCT01736176` - A Study to Assess the Safety and Efficacy of Levodopa-carbidopa Intestinal Gel (LCIG) for the Treatment of Non-motor Symptoms in Patients With Advanced Parkinson's Disease	Phase 3
	Completed	`NCT02082249` - An Extension Study to Assess the Safety, Tolerability and Efficacy of ABT-SLV187 in Subjects With Advanced Parkinson's Disease and Persistent Motor-Complications Despite Optimized Treatment With Available Anti-Parkinsonian Medications	Phase 3
	Completed	`NCT02611713` - Observational Study Evaluating Long-Term Effectiveness of Duodopa/Duopa in Patients With Advanced Parkinson's Disease
	Terminated	`NCT01536015` - Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction	Phase 3
	Completed	`NCT00357994` - Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects	Phase 3
	Completed	`NCT00335153` - Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced Parkinson's Disease	Phase 3
	Active, not recruiting	`NCT06396494` - An Automated Navigation System for Deep Brain Electrode Implantation
	Completed	`NCT00660387` - Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects	Phase 3